[{"begin": 255, "end": 322, "text": "for neurofibromatosis type 2 Clinical cancer research : an official", "tokenized_text": "for neurofibromatosis type 2 Clinical cancer research : an official", "type": "title", "id": 0}, {"begin": 323, "end": 378, "text": "journal of the American Association for Cancer Research", "tokenized_text": "journal of the American Association for Cancer Research", "type": "venue", "id": 1}, {"begin": 380, "end": 384, "text": "2013", "tokenized_text": "2013", "type": "year", "id": 2}, {"begin": 0, "end": 204, "text": "Tanaka Karo, Eskin Ascia, Chareyre Fabrice, Jessen Walter J, Manent Jan, Niwa-Kawakita Michiko, Chen Ruihong, White Cory H, Vitte Jeremie, Jaffer Zahara M, Nelson Stanley F, Rubenstein Allan E, Giovannini", "tokenized_text": "Tanaka Karo , Eskin Ascia , Chareyre Fabrice , Jessen Walter J , Manent Jan , Niwa - Kawakita Michiko , Chen Ruihong , White Cory H , Vitte Jeremie , Jaffer Zahara M , Nelson Stanley F , Rubenstein Allan E , Giovannini", "type": "authors", "id": 3}, {"begin": 213, "end": 254, "text": "Therapeutic potential of HSP90 inhibition", "tokenized_text": "Therapeutic potential of HSP90 inhibition", "type": "title", "id": 4}]